BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19141248)

  • 1. [Prognostic factors of medullary thyroid carcinoma].
    Zhang Q; Yang CS; Guo ZM; Zeng ZY; Yang AK; Lai FY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Dec; 43(12):939-43. PubMed ID: 19141248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
    Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
    Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medullary carcinoma of the thyroid gland. Prognostic factors].
    Gavilán I; Astorga R; Sasián S; Acosta D; Aguilar M; Leal A; Escobar L; Córdoba JA; Girón JA
    Rev Clin Esp; 1996 Feb; 196(2):92-8. PubMed ID: 8685495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
    Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
    Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insullar cancer. Diagnosis and place in the structure of thyroid carcinoma].
    Pavlovskaia AI; Rotin DL; Savelov NA; Gurevich LE; Smirnova EA; Shishkov RV
    Arkh Patol; 2005; 67(6):16-8. PubMed ID: 16405014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
    Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
    Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical therapy of differentiated thyroid gland carcinoma].
    Walgenbach S; Sternheim E; Bittinger F; Junginger T
    Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
    Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological variants of thyroid medullary carcinoma].
    Raĭkhlin NT; Smirnova EA; Satylganov IZh
    Arkh Patol; 2001; 63(3):10-4. PubMed ID: 11452645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medullary carcinoma of the thyroid. A report of 4 clinical cases and a review of the literature].
    Russo F; Spina C; Arturi A; Rulli F; Barone Adesi TL; Gentileschi P; Forlini A
    Minerva Chir; 1997 Apr; 52(4):475-84. PubMed ID: 9265135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary thyroid carcinoma: prognostic factors].
    Pelizzo MR; Busnardo B; Bernante P; Girelli ME; Nacamulli D; Toniato A; Piotto A
    Minerva Chir; 1993 Nov; 48(21-22):1289-91. PubMed ID: 8152559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node yield as a prognostic factor in cancer studies--due to undersampling of tumor-free lymph nodes at higher N stages?
    Metze K
    Ann Surg Oncol; 2009 Apr; 16(4):1080-2; author reply 1083. PubMed ID: 18787904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thyroid cancers].
    Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphadenectomy in thyroid gland carcinoma--staging and therapy].
    Pomorski L; Rybinski K
    Zentralbl Chir; 1996; 121(6):455-8. PubMed ID: 8767330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult medullary carcinoma of the thyroid.
    Vaideeswar P; Desai MS; Vora IM
    Indian J Pathol Microbiol; 1994 Dec; 37 Suppl():S43-4. PubMed ID: 8613173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.